Product Description
SCEMBLIX is a prescription medicine used to treat adults with:
- Newly diagnosed or previously treated Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP)
- The approval of SCEMBLIX in patients newly diagnosed is based on a study that measured major molecular response (MMR) rate. There are ongoing studies to confirm the clinical benefit of SCEMBLIX for this use and how SCEMBLIX works over a longer period of time
- Ph+ CML in CP with the T315I mutation
It is not known if SCEMBLIX is safe and effective in children.